Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Effect on survival of acute myocardial infarction in Killip classes II or III patients undergoing invasive coronary procedures
Autore:
Rott, D; Behar, S; Leor, J; Hod, H; Boyko, V; Mandelzweig, L; Gottlieb, S;
Indirizzi:
Chaim Sheba Med Ctr, Neufeld Cardiac Res Inst, IL-52621 Tel Hashomer, Israel Chaim Sheba Med Ctr Tel Hashomer Israel IL-52621 21 Tel Hashomer, Israel Bikur Cholim Hosp, Heiden Dept Cardiol, Jerusalem, Israel Bikur Cholim Hosp Jerusalem Israel iden Dept Cardiol, Jerusalem, Israel
Titolo Testata:
AMERICAN JOURNAL OF CARDIOLOGY
fascicolo: 6, volume: 88, anno: 2001,
pagine: 618 - 623
SICI:
0002-9149(20010915)88:6<618:EOSOAM>2.0.ZU;2-F
Fonte:
ISI
Lingua:
ENG
Soggetto:
CARDIOGENIC-SHOCK; MANAGEMENT; THROMBOLYSIS; OUTCOMES; TRIAL; RISK;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
13
Recensione:
Indirizzi per estratti:
Indirizzo: Gottlieb, S Chaim Sheba Med Ctr, Neufeld Cardiac Res Inst, IL-52621 Tel Hashomer, Israel Chaim Sheba Med Ctr Tel Hashomer Israel IL-52621 mer, Israel
Citazione:
D. Rott et al., "Effect on survival of acute myocardial infarction in Killip classes II or III patients undergoing invasive coronary procedures", AM J CARD, 88(6), 2001, pp. 618-623

Abstract

The purpose of the present study was to determine whether patients with acute myocardial infarction (AMI) in Killip class II or III are likely to benefit from catheterization and coronary revascularization performed within 30 days of AML The study population was drawn from 2 national surveys performed during 1996 and 1998 in 26 coronary care units operating in Israel. Ouranalysis included 3,113 patients with AMI who were divided into 2 groups according to their admission Killip class: 2,484 patients (80%) in Killip class I, of whom 1,408 (57%) underwent cardiac catheterization and 1,076 weretreated noninvasively; and 629 patients in Killip class II or III, of whom314 (50%) underwent cardiac catheterization and 315 were managed conservatively. Patients in Killip class II or III who were treated invasively had lower mortality rates than their counterparts who were treated noninvasivelyat 30 days: 7.6% versus 15.6%, respectively (adjusted odds ratio [OR] 0.52, 95% confidence interval [CI] 0.28 to 0.92), and thereafter from 30 days to 6 months, 4.3% versus 13.6%, respectively (OR 0.34, 95% CI 0.16 to 0.68). In Killip class I patients, an invasive versus noninvasive management was not associated with a better outcome at 30 days: 1.6% versus 3.2%, respectively (OR 0.58, 95% CI 0.32 to 1.05), but with similar mortality rates at 30days to 6 months, 1.9% versus 2.0%, respectively (OR 1.46, 95% CI 0.79 to 2.74). Thus, the present study suggests that patients with AMI in Killip class II or III on admission may benefit from cardiac catheterization and revascularization performed within 30 days from admission, whereas patients with AMI in Killip class I are less likely to benefit from this approach. (C)2001 by Excerpta Medica, Inc.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/01/20 alle ore 11:37:17